ETHZ
Price
$2.51
Change
+$0.18 (+7.73%)
Updated
Sep 26 closing price
Capitalization
402.04M
WVE
Price
$6.80
Change
+$0.14 (+2.10%)
Updated
Sep 26 closing price
Capitalization
1.08B
40 days until earnings call
Interact to see
Advertisement

ETHZ vs WVE

Header iconETHZ vs WVE Comparison
Open Charts ETHZ vs WVEBanner chart's image
ETHZilla
Price$2.51
Change+$0.18 (+7.73%)
Volume$7.11M
Capitalization402.04M
Wave Life Sciences
Price$6.80
Change+$0.14 (+2.10%)
Volume$2.26M
Capitalization1.08B
ETHZ vs WVE Comparison Chart in %
Loading...
ETHZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETHZ vs. WVE commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETHZ is a Buy and WVE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ETHZ: $2.51 vs. WVE: $6.80)
Brand notoriety: ETHZ and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETHZ: 23% vs. WVE: 64%
Market capitalization -- ETHZ: $373.21M vs. WVE: $1.06B
ETHZ [@Biotechnology] is valued at $373.21M. WVE’s [@Biotechnology] market capitalization is $1.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETHZ’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • ETHZ’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, ETHZ is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETHZ’s TA Score shows that 3 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • ETHZ’s TA Score: 3 bullish, 5 bearish.
  • WVE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ETHZ and WVE are a bad buy in the short-term.

Price Growth

ETHZ (@Biotechnology) experienced а -0.79% price change this week, while WVE (@Biotechnology) price change was -1.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.08B) has a higher market cap than ETHZ($402M). ETHZ YTD gains are higher at: 37.912 vs. WVE (-45.028). ETHZ has higher annual earnings (EBITDA): -9.46M vs. WVE (-134.84M). WVE has more cash in the bank: 208M vs. ETHZ (2.22M). ETHZ has less debt than WVE: ETHZ (1.41M) vs WVE (21.7M). WVE has higher revenues than ETHZ: WVE (93.9M) vs ETHZ (0).
ETHZWVEETHZ / WVE
Capitalization402M1.08B37%
EBITDA-9.46M-134.84M7%
Gain YTD37.912-45.028-84%
P/E RatioN/AN/A-
Revenue093.9M-
Total Cash2.22M208M1%
Total Debt1.41M21.7M7%
FUNDAMENTALS RATINGS
ETHZ vs WVE: Fundamental Ratings
ETHZ
WVE
OUTLOOK RATING
1..100
153
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3690
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (53) in the Biotechnology industry is somewhat better than the same rating for ETHZ (89) in the Financial Conglomerates industry. This means that WVE’s stock grew somewhat faster than ETHZ’s over the last 12 months.

WVE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ETHZ (100) in the Financial Conglomerates industry. This means that WVE’s stock grew similarly to ETHZ’s over the last 12 months.

WVE's SMR Rating (100) in the Biotechnology industry is in the same range as ETHZ (100) in the Financial Conglomerates industry. This means that WVE’s stock grew similarly to ETHZ’s over the last 12 months.

ETHZ's Price Growth Rating (36) in the Financial Conglomerates industry is somewhat better than the same rating for WVE (90) in the Biotechnology industry. This means that ETHZ’s stock grew somewhat faster than WVE’s over the last 12 months.

ETHZ's P/E Growth Rating (97) in the Financial Conglomerates industry is in the same range as WVE (100) in the Biotechnology industry. This means that ETHZ’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETHZWVE
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ETHZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHPLF25.61N/A
N/A
BHP Group Limited
BPKKF5.80N/A
N/A
BP Castrol KK
SCTBF14.75N/A
N/A
Securitas A B
WZZZY4.15N/A
N/A
Wizz Air Holdings PLC
RMTO0.14N/A
N/A
RM2 International, Inc.

ETHZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETHZ has been loosely correlated with HURA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ETHZ jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETHZ
1D Price
Change %
ETHZ100%
+7.73%
HURA - ETHZ
56%
Loosely correlated
N/A
PRQR - ETHZ
45%
Loosely correlated
+1.21%
WVE - ETHZ
40%
Loosely correlated
+2.03%
KRRO - ETHZ
38%
Loosely correlated
+6.37%
BDRX - ETHZ
33%
Poorly correlated
-1.21%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+2.10%
PRQR - WVE
60%
Loosely correlated
+1.93%
KRRO - WVE
50%
Loosely correlated
+6.58%
OCUL - WVE
48%
Loosely correlated
+2.37%
DRUG - WVE
44%
Loosely correlated
+0.71%
KYMR - WVE
41%
Loosely correlated
+4.68%
More